Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Anthony Fauci. Photo: Greg Nash-Pool/Getty Images

NIAID director Anthony Fauci told CBS' "Face the Nation" Sunday the Pfizer coronavirus booster shot may be ready by the date the administration has aimed for, while Moderna's will likely need more time for approval.

The backdrop: President Biden said last month the government will offer boosters beginning the week of Sept. 20 to adults who got their shots of Pfizer-BioNTech or Moderna at least eight months prior.

What he's saying: “We were hoping that we would get the, both the candidates, both products, Moderna and Pfizer, rolled out by the week of the 20th," Fauci said. "It is conceivable that we will only have one of them out, but the other would likely follow soon thereafter."

  • Fauci added that the delay is because the administration wants to get "the appropriate FDA regulatory approval and then the recommendation from the Advisory Committee on Immunization Practices."
  • "Looks like Pfizer has their data in, likely would meet the deadline," he said. "We hope that Moderna would also be able to do it, so we could do it simultaneously, but if not, we'll do it sequentially."
  • "So the bottom line is very likely at least part of the plan will be implemented, but ultimately the entire plan will be."

Driving the news: Health officials have warned that the administration would have to scale back plans to unveil the third dose by that date to allow for more time to collect and review data for the Moderna booster.

Of note: "It looks good,” Fauci said when asked about the data that officials are still seeking from Moderna. “I think it is going to be at the most, a couple of weeks' to a few weeks' delay, if any.”

Go deeper

Updated Oct 14, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Moderna has become the world's vaccine boogeyman — Booster shots overtake first doses in the U.S. — Pfizer to vaccinate entire Brazilian city as part of study.
  2. Health: New cases down, but the West is at risk — Low vaccination rates exacerbate America's caregiving crisis — COVID is here to stay. So what does "victory" look like?
  3. Politics: NHL announces all but four players have been vaccinated — WHO names new advisory group on COVID origins — Biden admin warns Moderna to "step up" global vaccine supply.
  4. Education: LA extends deadline for school employee vaccinations amid staffing shortage — Parent sues Wisconsin school district after child tests positive — Arizona can't use aid for anti-mask education grants, Treasury says.
  5. Variant tracker: Where different strains are spreading.
Oct 14, 2021 - Health

FDA will review Merck COVID-19 pill

The Merck logo. Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images.

The U.S. Food and Drug Administration announced on Thursday that it will meet on Nov. 30th to review Merck's experimental oral antiviral COVID-19 treatment

Why it matters: An oral antiviral drug designed to prevent or treat COVID-19 could be a key tool to combat the pandemic. Merck ended its vaccine development in January.

20 hours ago - Health

Maine health care staff won't get unemployment benefits if they refuse vaccine

A pharmacy technicinan specialist at Maine Medical Center in South Portland, Maine. Photo: Derek Davis/Portland Press Herald via Getty Images

Maine health care workers who face firing for defying COVID vaccine requirements will not be eligible to receive unemployment benefits, AP reports.

Why it matters: The notice comes as Maine's hospitals suffer labor shortages partly related to the state's vaccine mandate. One of the state's biggest hospitals has had to turn away trauma and pediatric patients and shutter an entire department, according to a local CBS affiliate.